Found 5 matching trials
The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
PHASE2The primary objective of this study is to evaluate the safety and efficacy ...
Location
University of Alabama at Birmingham
Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
PHASE2To evaluate the feasibility, safety and tolerability of aerosolized lucinac...
Location
University of California, San Diego Medical Center - Hillcrest
KL₄Surfactant Treatment in Patients With ARDS
PHASE2Lung wash with KL₄Surfactant of individual lung segments using a bronchosco...
Location
Discovery Laboratories, Inc.
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
PHASE3OBJECTIVES:
Evaluate the safety and efficacy of lucinactant administered b...
Location
Discovery Laboratories, Inc.
Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
PHASE2Treatment with lucinactant, a peptide-containing synthetic lung surfactant,...
Location
Call for information